Expanding Clinical Pipelines, Contract Manufacturing Adoption, and Automation-Led Process Innovation Fuel Robust Market Growth Globally.Austin, United States, Feb. 27, 2026 (GLOBE NEWSWIRE) -- ...
Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...
CAPEX investment for setting up the PERC production is higher in the case of a MLD setup. Image: Fraunhofer ISE A solar cell manufacturing plant can reduce water consumption by up to 79% with existing ...
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
Solar cell photovoltaic research, development, and manufacturing continue to rapidly move forward with new advances in solar texture and metallization manufacturing leading to higher efficiency solar ...
Solar supply chain in China increased by 29% in 2024. Image: Avaada Group. Australian thinktank Climate Energy Finance (CEF) has forecast global solar module manufacturing capacity to reach 1.8TW by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results